Herpes viruses are notorious for their ability to hide from the immune system and establish lifelong infections. Researchers at Washington University School of Medicine in St. Louis have discovered how one mouse herpes virus escapes detection. The study appears in the January issue of the journal Immunity.
"These findings not only provide a better understanding of viral infections," says study leader Ted H. Hansen, Ph.D., professor of genetics, "they also offer novel insights into basic cellular processes in the immune system."
Like police cars cruising a neighborhood, immune cells known as cytotoxic T cells patrol the body looking for signs of trouble, such as virus-infected cells.
Cells communicate with the immune system by displaying protein fragments on their surface, including viral proteins. When cytotoxic T cells find viral proteins on a cells surface, they destroy the cell and thereby eliminate the virus.
Molecules known as major histocompatibility complex class 1 (MHC class 1) are responsible for displaying the protein fragments, known as peptides, on the cell surface. Cells make fleets of MHC class 1 molecules, each of which is assembled from two separate pieces plus the peptide. After each MHC class 1 molecule is completed, it travels to the cell surface to display its peptide to passing immune cells.
"MHC class I is the bodys most important mechanism for fighting off most viral infections," says lead author Lonnie P. Lybarger, Ph.D., postdoctoral fellow in genetics. "Not surprisingly, herpes viruses have evolved ways to block that immune response."
Hansen, Lybarger and their colleagues used a mouse virus known as gamma2-herpesvirus to discover exactly how the virus does this. The virus is closely related to the human herpes virus associated with Kaposis sarcoma, a cancer of blood vessels that occurs in some people with AIDS.
Research has shown that cells assemble MHC class 1 molecules with the help of other molecules known as chaperones. In this study, the investigators found that in cells infected with gamma2-herpesvirus, a viral protein known as mK3 joins the chaperones as they prepare to assemble an MHC class 1 molecule.
Then, as assembly occurs, the mK3 protein makes a subtle change in the MHC class 1 molecule that marks it as waste. So instead of traveling to the cell surface as it should, the MHC class 1 molecule is shunted off to the side and destroyed.
"The finding that mK3 requires chaperone molecules to function and hides out with them came as a surprise," says Lybarger. "It represents a new strategy for blocking immune detection, and it suggests that there are probably other viral proteins that use host molecules to target MHC class 1."
The researchers are using gamma2-herpesvirus and the herpes virus associated with Kaposis sarcoma to identify some of those additional protein-protein interactions between virus and host.
Hansen attributes the success of this project to an effective collaboration between his laboratory, which specializes in the presentation of MHC class 1 molecules, and the virology laboratory of Herbert W. Virgin IV, M.D., Ph.D., professor of pathology and immunology and of molecular microbiology.
Lybarger L, Wang X, Harris MR, Virgin HW, Hansen TH. Virus subversion of the MHC class 1 peptide-loading complex. Immunity, January 2003.
Funding from the National Institute of Allergy and Infectious Diseases supported this research.
Darrell E. Ward | Source: EurekAlert!
Further information: medinfo.wustl.edu/
More articles from Health and Medicine:
Immune system activated in schizophrenia
20.11.2009 | Karolinska Institutet
New research helps explain why bird flu has not caused a pandemic
20.11.2009 | Imperial College London
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News